Related Experiment Videos
Molecular mimicry of growth factors by products of tumor viruses
1Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells.
Journal of immunology (Baltimore, Md. : 1950)·2000
Epithelial cell plasticity in neoplasia.
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine.
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
A role for cholinesterases in tumorigenesis?
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.
Cancer cells (Cold Spring Harbor, N.Y. : 1989)·1991
Recent applications of asymmetric hydrogenation in total synthesis of natural products and drugs.
Chemical Society reviews·2026
A new oligolignan and a new phenylpropanoid from the roots of Polygala tenuifolia with anti-neuroinflammatory activity.
Journal of Asian natural products research·2026
Nanoengineered STING agonists for cancer therapy: toward immunodynamic control.
Journal of hematology & oncology·2026
Antioxidant activity and cytotoxic effects of Benincasa hispida juice on HepG2 cells.
BMC complementary medicine and therapies·2026
Discovery of YA8026, an optimized human constitutive androstane receptor activator from a novel ML241-derived scaffold.
European journal of medicinal chemistry·2026
Identification of selective FGFR2/4 degraders with potent antiproliferative activity.
European journal of medicinal chemistry·2026